Findings from the GOG-3007 study suggest everolimus plus letrozole might be effective in advanced persistent or recurrent endometrial carcinoma.
Bryant Furlow
Advertisement
Articles by Bryant Furlow
Advertisement
Latest Updated Articles
- Everolimus Plus Letrozole Effective in Endometrial Carcinoma
Published: March 27th 2018 | Updated: December 19th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
Cadonilimab Yields 100% 24-Month OS in Recurrent Cervical Cancer Population
2
FDA Grants Approval to Teclistamab Combo in RRMM
3
Trifluridine/Tipiracil-Associated Neutropenia Associated With Improved Outcomes in mCRC
4
LITESPARK-022: Belzutifan Plus Pembrolizumab Boosts DFS in High-Risk ccRCC
5